AMRI Profile
Albany Molecular Research, Inc. (AMRI) was a contract research and manufacturing organization (CRMO) that provided services to the pharmaceutical, biotechnology, and related industries. The company was founded in 1991 and was headquartered in Albany, New York, in the United States.
AMRI offered a range of services, including drug discovery and development, custom synthesis, analytical services, and manufacturing and purification of active pharmaceutical ingredients (APIs) and drug products. The company's clients included large pharmaceutical companies, biotechnology startups, and government agencies.
In 2017, AMRI was acquired by private equity firm The Carlyle Group and became a privately-held company. Under the terms of the acquisition, AMRI shareholders received $21.75 per share in cash, representing a total transaction value of approximately $922 million.
|
